MolMed now part of AGC Biologics | LinkedIn
COVID-19 impacting Cell&Gene therapy manufacturing Webinar | molmed
MolMed, Fininvest aderisce all'OPA e cede quota 23,1%
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
I buy di oggi da Anima a MolMed
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
home | molmed
MolMed - YouTube
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
Prezzi da saldo a Piazza Affari, rischio Opa straniere. Giapponesi su MolMed
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
MolMed now part of AGC Biologics | LinkedIn
MolMed now part of AGC Biologics | LinkedIn
Relazione sulla Remunerazione MolMed S.p.A.
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
Half-Year Financial Report at June 30th, 2020
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not
Meeting agenda | molmed
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
home | molmed
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
Innovazione, la Borsa corre con plastica e super batteri - Corriere.it
PROSPETTO INFORMATIVO MolMed S.p.A.
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
